GlobalData’s detailed strategic reports on the MFN executive order and on the GENEROUS model examined how some of the known ...
Under the new healthcare payment model known as ‘reference-based pricing,’ employers bypass the traditional insurance carrier contract and pay hospitals directly. The amount paid is based on a ...
This qualitative study finds low employer adoption of reference-based pricing (RBP) benefit design and that redesign of RBP may be necessary to overcome barriers to adoption. Objectives: There is ...
Reference-based pricing entered the conversation a few years ago as a solution and response to unsustainable healthcare price increases, and the model is still gaining traction among self-funded ...
Federal agencies may need to step in and tighten the rules of reference pricing before they cause more harm than good. Reference pricing, for the most part, is a good concept, but it does raise issues ...
The MFN model aims to align US drug prices with those in select OECD countries, potentially reducing costs but raising access and innovation concerns. The End Price Gouging for Medications Act ...
Faced with high and rising health care costs, some Vermont policymakers are eyeing a new strategy to address the problem. Reference-based pricing, a system in which officials limit how much hospitals ...
Reference-based pricing combined with employer education and an online shopping tool significantly improved members' utilization of lab services at or below the reference price The study group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback